你知道吗？在基因编辑领域，新的突破常常能引发轩然大波。最近，广州市宝创生物技术有限公司成功取得了一项关于CRISPR-Cas13a系统的非连续靶标激活模式及应用的专利，这一消息无疑让无数生物科技爱好者与研究人员感到振奋。然而，这项新专利到底意味着什么？它将如何改变未来的基因治疗与生物技术发展？

This study designs a DNA logic gate system integrating nucleic acid aptamers, catalytic hairpin assembly (CHA), and CRISPR-Cas12a, pioneering its use for AML antigen detection. The system comprises ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

目前，虽然有一些检测 FAdV-4 的方法，如 TaqMan-based 实时荧光定量聚合酶链式反应（qPCR）、数字 PCR、环介导等温扩增（LAMP）实时浊度法和基于 CRISPR/Cas13a 的侧向流动分析法等，但这些方法或多或少都存在一些问题。血清学检测方法特异性和敏感性低，早期感染 ...

State Key Laboratory of Advanced Environmental Technology, Department of Environmental Science and Engineering, University of Science and Technology of China, Hefei 230026, China ...

As the race between U.S. and Chinese biotech companies heats up, the competition is particularly fierce in one field: CRISPR gene editing. China has rapidly emerged as a global leader in CRISPR ...

Researchers designed a CRISPR-based test that rapidly detects low levels of pathogen genetic material in blood. This is done without the need for nucleic acid amplification. In CRISPR/Cas-based ...

CRISPR-Cascade, including sample preparation, requires about half an hour, making it the fastest available bloodstream infection diagnostic. There is also the potential to improve sample prep ...